Public Health Experts Call for an End to Overregulation of Mifepristone

Date: 
23/02/2017 - 13:05

A new commentary in the New England Journal of Medicine highlights how the FDA’s overregulation of mifepristone (the abortion pill) is medically unnecessary AND harmful to women seeking care. They suggest that Mifepristone’s 16 years of safe & effective use in the U.S. prove it’s time to remove needless barriers.

Read the complete commentary >>>

 

 

Become a member

Our newsletter

Webinar

 Webinar

 

 

Congress

Facebook